ATE182787T1 - Ophthalmische zusammensetzungen, die kombinationen von einem carboanhydrase-inhibitor und einem beta-adrenergischen antagonist enthalten - Google Patents

Ophthalmische zusammensetzungen, die kombinationen von einem carboanhydrase-inhibitor und einem beta-adrenergischen antagonist enthalten

Info

Publication number
ATE182787T1
ATE182787T1 AT92303330T AT92303330T ATE182787T1 AT E182787 T1 ATE182787 T1 AT E182787T1 AT 92303330 T AT92303330 T AT 92303330T AT 92303330 T AT92303330 T AT 92303330T AT E182787 T1 ATE182787 T1 AT E182787T1
Authority
AT
Austria
Prior art keywords
beta
compositions containing
adrenergic antagonist
ophthalmic compositions
containing combinations
Prior art date
Application number
AT92303330T
Other languages
English (en)
Inventor
John J Baldwin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27103852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE182787(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE182787T1 publication Critical patent/ATE182787T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92303330T 1991-04-17 1992-04-14 Ophthalmische zusammensetzungen, die kombinationen von einem carboanhydrase-inhibitor und einem beta-adrenergischen antagonist enthalten ATE182787T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68671891A 1991-04-17 1991-04-17
US83491392A 1992-02-13 1992-02-13

Publications (1)

Publication Number Publication Date
ATE182787T1 true ATE182787T1 (de) 1999-08-15

Family

ID=27103852

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92303330T ATE182787T1 (de) 1991-04-17 1992-04-14 Ophthalmische zusammensetzungen, die kombinationen von einem carboanhydrase-inhibitor und einem beta-adrenergischen antagonist enthalten

Country Status (24)

Country Link
EP (1) EP0509752B1 (de)
JP (1) JP2527513B2 (de)
KR (1) KR920019348A (de)
CN (1) CN1073421C (de)
AT (1) ATE182787T1 (de)
AU (1) AU648659C (de)
CA (1) CA2065965C (de)
CH (1) CH0509752H1 (de)
CY (1) CY2146B1 (de)
CZ (1) CZ285129B6 (de)
DE (3) DE69229688C5 (de)
DK (1) DK0509752T3 (de)
ES (1) ES2133304T3 (de)
GR (1) GR3031467T3 (de)
IE (1) IE921240A1 (de)
IL (1) IL101537A (de)
LU (1) LU90506I2 (de)
MX (1) MX9201785A (de)
NL (1) NL990041I2 (de)
NO (1) NO306196B1 (de)
RO (1) RO113612B1 (de)
SK (1) SK282039B6 (de)
WO (1) WO1992018124A1 (de)
YU (1) YU39392A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932572A (en) * 1992-02-21 1999-08-03 Alcon Laboratories, Inc. Topical anti-glaucoma compositions
ES2118941T3 (es) * 1992-02-21 1998-10-01 Alcon Lab Inc Composiciones antiglaucoma topicas que comprenden inhibidores de anhidrasa carbonica y bloqueantes beta.
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
FI981473A7 (fi) * 1998-06-25 1999-12-26 Orion Yhtymae Oyj Menetelmä pulmonaalihypertension hoitamiseksi
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
CN100345594C (zh) * 2004-01-19 2007-10-31 无锡杰西医药科技有限公司 乙酰唑胺滴眼液
US8211450B2 (en) * 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
RU2624534C2 (ru) 2010-07-29 2017-07-04 Аллерган, Инк. Растворы биматопроста и тимолола, не содержащие консервантов
JP5893204B1 (ja) * 2015-02-23 2016-03-23 参天製薬株式会社 防腐効果のある医薬の組合せ
JP6132968B1 (ja) * 2016-01-29 2017-05-24 参天製薬株式会社 ドルゾラミド、高分子およびホウ酸を含有する医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use

Also Published As

Publication number Publication date
IL101537A (en) 1997-11-20
DK0509752T3 (da) 1999-12-06
DE10075002I2 (de) 2004-07-01
NO933714D0 (no) 1993-10-15
JPH05117167A (ja) 1993-05-14
CN1073421C (zh) 2001-10-24
WO1992018124A1 (en) 1992-10-29
IE921240A1 (en) 1992-10-21
CZ285129B6 (cs) 1999-05-12
GR3031467T3 (en) 2000-01-31
DE69229688C5 (de) 2010-10-21
MX9201785A (es) 1992-10-01
HK1009251A1 (en) 1999-05-28
DE69229688T2 (de) 2000-02-24
EP0509752A2 (de) 1992-10-21
AU648659B2 (en) 1994-04-28
CA2065965A1 (en) 1992-10-18
NO306196B1 (no) 1999-10-04
IL101537A0 (en) 1992-12-30
AU648659C (en) 2008-02-14
KR920019348A (ko) 1992-11-19
RO113612B1 (ro) 1998-09-30
SK110393A3 (en) 1994-02-02
NO933714L (no) 1993-10-15
CA2065965C (en) 1998-06-16
NL990041I1 (nl) 2000-02-01
EP0509752A3 (en) 1993-03-03
CZ209893A3 (en) 1994-06-15
JP2527513B2 (ja) 1996-08-28
DE69229688T4 (de) 2010-08-19
CN1066781A (zh) 1992-12-09
LU90506I2 (fr) 2000-03-28
ES2133304T3 (es) 1999-09-16
YU39392A (sh) 1995-12-04
CY2146B1 (en) 2002-06-21
AU1497992A (en) 1992-10-22
CH0509752H1 (de) 2012-11-30
EP0509752B1 (de) 1999-08-04
DE69229688D1 (de) 1999-09-09
SK282039B6 (sk) 2001-10-08
DE10075002I1 (de) 2000-03-30
NL990041I2 (nl) 2000-04-03

Similar Documents

Publication Publication Date Title
DE59310329D1 (de) Neue Sulfonamide
DE69229688D1 (de) Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten
FI901289A7 (fi) Muistia ja oppimista parantava tai kognitiivisten tai psykoottisten häiriöiden hoidossa käytettävä koostumus, joka sisältää D-sykloseriiniä ja D-alaniinia
ATE273009T1 (de) Substituierte tetrahydrofuran-analoge von prostaglandinen als augendrucksenkende mittel
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
DE69116705D1 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
DE69418947D1 (de) Stilbenderivate und analoga sowie deren anwendung
EP0631772A3 (de) Retinoid enthaltendes Mittel.
FR2656214B1 (fr) Cadre dynamique d'osteosynthese du rachis.
DE58908544D1 (de) Benzamid gegen kognitive Erkrankungen.
DE69330272D1 (de) 4-imidomethyl-1-[2'-phenyl-2-oxoethyl]-piperidine als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendung
EP0667160A3 (de) Anwendung von Prostagrandin-Analogen für die Behandlung von Glaukome und okuläre Hypertension.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE3886314D1 (de) Substituierte Thieno(2,3-b) thiophen-2-sulfonamide als Mittel gegen Glaukoma.
ATE25195T1 (de) Verwendung von d,l- und d-carazolol zur herstellung von antiglaukommitteln sowie arzneimittel, die d-carazolol enthalten.
ATE107165T1 (de) Verwendung von macrolactonen als antiallergica.
SE8802323L (sv) 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma
IT1238082B (it) Farmaco per trattare l'ipertensione a base di un antagonista dei recettori del tromossano a2 e nuove combinazioni
RU92015818A (ru) Способ для лечения энуреза
ITBO950086A0 (it) Uso di 2, 3-diidro-4(1h)-chinazolinoni e di composizioni farmaceutiche che li contengono nel trattamento dei disturbi dell'apprendimento e della memoria
RU93010415A (ru) Средство, восстанавливающее репродукцию у женщин при функциональных нарушениях гипоталамуса
IT1229511B (it) Dispositivo per la cura chirurgica dell'astigmatismo
ITFI950075V0 (it) Supporto per pallina utilizzabile per l'esercizio del coordinamento dei movimenti e/o per passatempo